Laura Jacobsen

Skip to main content All experts

ASO PROF

MD-PEDIATRICS

Orcid identifier0000-0002-5144-7836 (opens in a new tab)⁠

ASO PROF
MD-PEDIATRICS

lauraj@ufl.edu (opens in a new tab)

sort by:

GRANT
PRISE-hATG: Personalized Response and Immunologic Surveillance of Endogenous CPeptide Preservation in New, Recent, and Established Onset T1D Treated with Human Anti-Thymocyte Globulin
Sab Biotherapeutics1 Jul 2026 - 30 Jun 2030
Active
GRANT
A Randomized Phase I/II Trial of Low Dose Anti-thymocyte Globulin (ATG) with Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (WAVE T1D)
City of Hope10 Apr 2026 - 9 Apr 2031
Active
GRANT
A 52-Week Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 2a Study Assessing Safety and Efficacy of SAR442970, A Dual Anti TNF- -OX40L NANOBODY® molecule, for -Cell Function in Participants with Recently Diagnosed Type 1 Diabetes
Sanofi Us Services30 Mar 2026 - 31 Mar 2026
Closed
GRANT
Beta-Cell Preservation Project
T1d Exchange1 Jan 2026 - 30 Nov 2026
Active
GRANT
A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Dose Finding Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).
Sab Biotherapeutics10 Dec 2025 - 9 Dec 2030
Active
GRANT
Data Coordinating Center for Type 1 Diabetes TrialNet
National Institute of Health Niddk25 Nov 2025 - 31 May 2026
Expired
GRANT
Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes
National Institute of Health Niddk18 Aug 2025 - 30 Jun 2030
Active
GRANT
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes
Breakthrough T1d - Formerly Jdrf International24 Mar 2025 - 31 Oct 2028
Active
GRANT
Data Coordinating Center for Type 1 Diabetes TrialNet
National Institute of Health Niddk28 Feb 2025 - 30 Jun 2025
Expired
GRANT
Conceptualization of a Social Determinants of Mental and Behavioral Health (SDMBH) Screening Protocol in the Progression of Autoantibodies to Overt Type 1 Diabetes: An Exploratory Study to Advance Translation and Health Equity Using Technology
National Institute of Health Niddk1 Oct 2024 - 31 Dec 2026
Active
GRANT
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2
Breakthrough T1d - Formerly Jdrf International27 Aug 2024 - 31 Oct 2026
Active
GRANT
Immune Function and the Progression to Type 1 Diabetes
National Institute of Health Niaid11 Apr 2023 - 31 May 2028
Active
GRANT
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes
National Institute of Health Niddk14 Jul 2021 - 30 Apr 2026
Expired
GRANT
Home Video-Based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children (RedCHip)
National Institute of Health Niddk17 Dec 2020 - 31 Mar 2025
Expired
GRANT
TrialNet Clinical Center infrastructure support services
National Institute of Health Niddk14 Apr 2020 - 30 Jun 2025
Expired
GRANT
Diabetes Journey: From systematic screening to intervention
National Institute of Health Niddk27 Jan 2020 - 31 Mar 2024
Expired
GRANT
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients with New Onset or Established Type 1 Diabetes Mellitus
Tolerion18 Nov 2019 - 9 Sep 2021
Closed
GRANT
T cell receptor sequencing in type 1 diabetes - biomarker discovery and technology development
Helmsley Charitable Trust, Leona & Harry14 Sep 2018 - 30 Sep 2022
Expired
GRANT
Characterization of T cell Autoreactivity in Type 1 Diabetes
Breakthrough T1d - Formerly Jdrf International14 May 2018 - 13 Jun 2019
Expired
GRANT
PES Travel Grant
Eli Lilly and Corporation7 Jul 2017 - 31 May 2018
Expired
GRANT
TrialNet: University of Florida Clinical Center and Network
National Institute of Health Niddk29 Jul 2014 - 30 Apr 2020
Expired

GRANTS